A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
Clinical trial NCT06058000 · COMPLETED
Trial details
- NCT number
- NCT06058000
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-13
- Primary completion
- 2024-09-02
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.